Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells

Shuai Zhao1, Yuichiro Kanno, Momoka Nakayama

  • 1Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.

Cancer Letters
|November 30, 2011
PubMed

Insights

Activating the aryl hydrocarbon receptor (AhR) combats breast cancer by targeting cancer stem cells. This process reduces mammosphere formation and key self-renewal pathways like Wnt/β-catenin and Notch.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The aryl hydrocarbon receptor (AhR) is a transcription factor implicated in various cellular processes.
  • Emerging research highlights the potential anti-tumorigenic roles of AhR in breast cancer contexts.
  • The cancer stem cell hypothesis posits that a subset of tumor cells drives cancer growth and recurrence.

Purpose of the Study:

  • To investigate the anti-tumor effects of aryl hydrocarbon receptor (AhR) activation within the framework of the cancer stem cell hypothesis.
  • To determine if AhR activation influences key markers and pathways associated with cancer stem cells in breast cancer models.

Main Methods:

  • Utilized MCF-7 breast cancer cells to study AhR activation.
  • Assessed the impact of AhR activation on mammosphere formation, a measure of stem cell self-renewal.
  • Quantified the proportion of cells exhibiting high aldehyde dehydrogenase 1 (ALDH-1) activity, a marker for cancer stem cells.
  • Analyzed the modulation of Wnt/β-catenin and Notch signaling pathways following AhR activation.

Main Results:

  • AhR activation significantly suppressed mammosphere formation in MCF-7 cells.
  • A notable decrease in the percentage of cells with high ALDH-1 activity was observed upon AhR activation.
  • AhR activation led to the downregulation of critical self-renewal signaling pathways, including Wnt/β-catenin and Notch.

Conclusions:

  • AhR activation demonstrates anti-tumor effects in breast cancer by targeting cancer stem cell properties.
  • Suppression of mammosphere formation and ALDH-1 activity indicates a reduction in cancer stem cell populations.
  • Downregulation of Wnt/β-catenin and Notch signaling pathways by AhR contributes to its anti-cancer stem cell effects.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...